ClinicalTrials.gov
ClinicalTrials.gov Menu

A Phase I Study of Pyrimethamine in Patients With GM2 Gangliosidosis

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00679744
Recruitment Status : Withdrawn (Due to lack of funding)
First Posted : May 19, 2008
Last Update Posted : February 25, 2013
Sponsor:
Collaborators:
University Hospitals Cleveland Medical Center
New York University School of Medicine
The Hospital for Sick Children
Information provided by (Responsible Party):
Exsar Corporation

No Study Results Posted on ClinicalTrials.gov for this Study
Study was withdrawn before participants were enrolled.
  Recruitment Status : Withdrawn
  Actual Primary Completion Date : March 2010
  Study Completion Date : No date given